Skip directly to content

XELJANZ® (tofacitinib citrate) Medical Website | Safety Info

Resource Center

XELJANZ has been studied in combination with nonbiologic DMARDs and as monotherapy. The XELJANZ clinical development program included 6 randomized, controlled, double-blind studies.

more